# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-24-012924
Filing Date
2024-09-20
Accepted
2024-09-20 16:16:11
Documents
22
Period of Report
2024-11-05

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | pahc-20241105xdef14a.htm iXBRL | DEF 14A | 1599450
2 | GRAPHIC | pahc-20241105xdef14a_a003.jpg | GRAPHIC | 13940
3 | GRAPHIC | pahc-20241105xdef14a_a004.jpg | GRAPHIC | 5131
4 | GRAPHIC | pahc-20241105xdef14a_a019.jpg | GRAPHIC | 66490
5 | GRAPHIC | pahc-20241105xdef14a_a020.jpg | GRAPHIC | 64516
6 | GRAPHIC | pahc-20241105xdef14a_a021.jpg | GRAPHIC | 65898
7 | GRAPHIC | pahc-20241105xdef14a_a022.jpg | GRAPHIC | 44558
8 | GRAPHIC | pahc-20241105xdef14a_bg001.jpg | GRAPHIC | 162967
9 | GRAPHIC | pahc-20241105xdef14a_cg001.jpg | GRAPHIC | 107652
| Complete submission text file | 0001558370-24-012924.txt |  | 4030147

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | EX-101.SCH | pahc-20241105.xsd | EX-101.SCH | 7093
11 | EX-101.DEF | pahc-20241105_def.xml | EX-101.DEF | 51809
12 | EX-101.LAB | pahc-20241105_lab.xml | EX-101.LAB | 5378
13 | EX-101.PRE | pahc-20241105_pre.xml | EX-101.PRE | 4980
24 | EXTRACTED XBRL INSTANCE DOCUMENT | pahc-20241105xdef14a_htm.xml | XML | 364773

Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-36410 | Film No.: 241313589
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)